Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ascend Medical vs Willow

Ascend Medical
Graded #426

Lower grade

vs+2.3000000000000043
Willow
Graded #377

Higher grade

The verdict

Willow takes it — 58.2/100 to 55.9/100.

Willow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAscend Medical +9
45
36
Dose & formulationWillow +35
40
75
Clinical oversightAscend Medical +14
85
71
Labs & monitoringAscend Medical +10
62
52
FulfillmentWillow +6
59
65
Contract termsWillow +14
41
55
Ascend Medical · left barWillow · right bar

The numbers

MetricAscend MedicalWillow
WeighScore55.9/10058.2/100
GradeCC
Scorecard rank#426#377
SemaglutideNot disclosed$299/mo (starting dose, compounded)
TirzepatideNot disclosed$399/mo (starting dose, compounded)
Coverage2 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Ascend Medical

Graded #426 · C

Strengths

  • Whole-person virtual primary care that includes a medical weight loss program
  • Staffed by licensed MDs, DOs, NPs and PAs
  • Integrates weight loss with primary, mental health and diabetes care
  • Clear state availability (Georgia and Texas)

Where it loses points

  • Available only in Georgia and Texas
  • Specific GLP-1 medications and branded-vs-compounded status not published
  • No pricing disclosed on public pages
  • Weight loss is one service among many, not a dedicated GLP-1 specialist
Willow

Graded #377 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard